Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity
{{output}}
Disease modifying drugs and biologics used to treat autoimmune diseases, although promising, are non-curative. As the field moves towards development of new approaches to treat autoimmune disease, antigen-specific therapies immunotherapies (ASITs) have emerged... ...
